Dr. Zhou completed his research fellowship training in retinal and vitreous disease in Doheny Eye Institute (ranked No. 7 in U.S.), University of Southern California, after residency training at the Peking University People’s Hospital in Beijing, China. He received his medical doctor degree from Peking University (ranked No. 1 in China).
He was the associate professor of ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, and was the attending ophthalmologist of the department of ophthalmology, Eye Peking University People’s Hospital, Beijing.
Dr. Zhou has contributed to over fifteen years of clinical and surgical treatment of eye disorders. He first reported the safe effective lowest dose of verteporfin photodynamic therapy for acute central serous chorioretinopathy. He participated in developing the manual small incision 20-gauge pars plana vitrectomy. He also reported the long-term follow-up of local relaxing vitrectomy for stage 4 retinopathy of prematurity.
Furthermore, Dr Zhou is a clinician-scientist in ophthalmology. His academic interests are age-related diseases of the eye, with emphasis on the pathogenesis of cataract and age-related macular degeneration (AMD). His paper was published in many academic journals, including Nature Communications. He is the principal investigator (PI) of a National Natural Science Foundation of China that investigated why old people get age-related cataract. He wss the secretary of a National Basic Research Program of China (973 Program) that investigated the pathogenesis of AMD.
Dr. Zhou is the committee member of Chinese Ophthalmology Society, member of the American Academy of Ophthalmology (AAO) and the Association for Research in Vision and Ophthalmology (ARVO). He is a reviewer of ten international academic journals including Ophthalmology, American Journal of Ophthalmology (AJO), and British Journal of Ophthalmology (BJO). By 2017, he have published 18 articles in peer-reviewed journals, and made numerous national and international presentations. Dr Zhou was invited by Stephen J. Ryan to write two chapters for the fifth edition of Retina, the bible of retinal and vitreous diseases, which published in 2012 by Elsevier. He got the Distinguished Service Award, the highest award of the Asia-Pacific Academy of Ophthalmology (the second largest association of ophthalmologist of the world) in 2017.
Dr. Zhou works at Parkway Health Gleneagles Medical and Surgical Center, Tomorrow Square, 4th Floor, 389 Nanjing Xi Road, Shanghai. Please call 400-819-6622 to make appointment.